Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1172/JCI.INSIGHT.171585 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Sjögren’s disease is a chronic autoimmune disease characterized by symptoms of oral and ocular dryness and extraglandular manifestations. Mouth dryness is not only due to reduced saliva volume, but also to alterations in the quality of salivary mucins in patients with Sjögren’s disease. Mucins play a leading role in mucosa hydration and protection, where sulfated and sialylated oligosaccharides retain water molecules at the epithelial surface. The correct localization of glycosyltransferases and sulfotransferases within the Golgi apparatus determines adequate O-glycosylation and sulfation of mucins, which depends on specific golgins that tether enzyme-bearing vesicles. Here, we show that a golgin called Giantin was mislocalized in salivary glands from patients with Sjögren’s disease and formed protein complexes with Gal3-O-sulfotransferases (Gal3STs), which changed their localization in Giantin-knockout and -knockdown cells. Our results suggest that Giantin could tether Gal3ST-bearing vesicles and that its altered localization could affect Gal3ST activity, explaining the decreased sulfation of MUC5B observed in salivary glands from patients with Sjögren’s disease.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Nunez, Matilde | Mujer |
Universidad de Chile - Chile
|
| 2 | Carvajal, Patricia | Mujer |
Universidad de Chile - Chile
|
| 3 | Aguilera, Sergio | - |
Clínica INDISA - Chile
|
| 4 | BARRERA-ALVARADO, MARIA JOSE | Mujer |
Universidad San Sebastián - Chile
|
| 5 | Matus, Soledad | Mujer |
Universidad San Sebastián - Chile
|
| 6 | Couto, Alicia | - |
Universidad de Buenos Aires - Argentina
UNIV BUENOS AIRES - Argentina |
| 7 | Landoni, Malena | - |
Universidad de Buenos Aires - Argentina
UNIV BUENOS AIRES - Argentina |
| 8 | Boncompain, Gaelle | - |
Biologie Cellulaire et Cancer - Francia
PSL Res Univ - Francia Inst Neuromyogene - Francia |
| 9 | GONZALEZ-PROVIDELL, SERGIO | Hombre |
Universidad Mayor - Chile
|
| 10 | MOLINA-MUNOZ, CLAUDIA CAROLINA | Hombre |
Universidad San Sebastián - Chile
|
| 11 | Pino, Karina | - |
Universidad de Chile - Chile
|
| 12 | Indo, Sebastian R. | Hombre |
Universidad de Chile - Chile
|
| 13 | Figueroa, Lourdes | - |
Universidad de Chile - Chile
|
| 14 | González, María Julieta | - |
Universidad de Chile - Chile
|
| 14 | Gonzalez, Maria-Julieta | - |
Universidad de Chile - Chile
|
| 15 | CASTRO-MASSO, ISABEL VERONICA | Mujer |
Universidad de Chile - Chile
|
| Fuente |
|---|
| FONDEQUIP |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Universidad Austral de Chile |
| FONDECYT-Chile |
| FONDECYT postdoctoral fellowship |
| University College London |
| FONDECYT-Iniciacion |
| Københavns Universitet |
| ANID/BASAL |
| Ulla Mandel |
| Copenhagen Center for Glycomics |
| Agradecimiento |
|---|
| This research was supported by Fondecyt-Chile (1230852 to IC, MJG, SA, SG, and CM; 1210055 to MJG, SA, CM, SG, MJB, and IC; and 1241526 to MJB, MJG, SA, SG, and CM); Fondecyt-Iniciaci\u00F3n (11170049 to IC); FONDECYT Postdoctoral Fellowship (3240081 to PC); ANID/BASAL (FB210008 to SM); and FONDEQUIP (EQM170098). We thank all the patients who participated in this study. We gratefully acknowledge Dallas Swallow (University College London, United Kingdom) for providing anti-MUC5B (EU-MUC5Bb) and anti-MUC1 (M8) antibodies; Ulla Mandel (Copenhagen Center for Glycomics, University of Copenhagen, Copenhagen, Denmark) for providing anti-MUC7 (PANH3), anti-MUC5B (PANH2), and anti-GalNAcT1 (4D8) antibodies; Enno Veerman (Vrije Universiteit and Universiteit van Amsterdam, the Netherlands) for providing the anti\u2013Sulfo-Lewis a and c antibodies (F2); Shoko Nishihara (Soka University, Tokyo, Japan) for providing the anti-PAPST1 antibodies; and Gonzalo Mardones (Universidad Austral de Chile, Valdivia, Chile) for providing the anti-GOLPH3 antibodies. We also thank Daniela Jara for performing the histological procedures. |
| This research was supported by Fondecyt-Chile (1230852 to IC, MJG, SA, SG, and CM; 1210055 to MJG, SA, CM, SG, MJB, and IC; and 1241526 to MJB, MJG, SA, SG, and CM); Fondecyt-Iniciacion (11170049 to IC); FONDECYT Postdoctoral Fellowship (3240081 to PC); ANID/BASAL (FB210008 to SM); and FONDEQUIP (EQM170098). We thank all the patients who participated in this study. We gratefully acknowledge Dallas Swallow (University College London, United Kingdom) for providing anti-MUC5B (EU-MUC5Bb) and anti-MUC1 (M8) antibodies; Ulla Mandel (Copenhagen Center for Glycomics, University of Copenhagen, Copenhagen, Denmark) for providing anti-MUC7 (PANH3), anti-MUC5B (PANH2), and anti-GalNAcT1 (4D8) antibodies; Enno Veerman (Vrije Universiteit and Universiteit van Amsterdam, the Netherlands) for providing the anti-Sulfo-Lewis a and c antibodies (F2); Shoko Nishihara (Soka University, Tokyo, Japan) for providing the anti-PAPST1 antibodies; and Gonzalo Mardones (Universidad Austral de Chile, Valdivia, Chile) for providing the anti-GOLPH3 antibodies. We also thank Daniela Jara for performing the histological procedures. |